Ketone ester administration improves glycemia in obese miceSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Peter A. Crawford et al.|American Journal of Physiology-Cell Physiology|2023Cited by 18
The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA TransferaseSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Amanda A. Greenwell et al.|Diabetes|2022Cited by 14
The antipsychotic dopamine 2 receptor antagonist diphenylbutylpiperidines improve glycemia in experimental obesity by inhibiting succinyl-CoA:3-ketoacid CoA transferaseSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Amanda A. Greenwell et al.|Unknown|2022Cited by 1
The antipsychotic dopamine 2 receptor antagonist diphenylbutylpiperidines improve glycemia in experimental obesity by inhibiting succinyl-CoA:3-ketoacid CoA transferaseSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Amanda A. Greenwell et al.|Unknown|2022Cited by 0
The antipsychotic dopamine 2 receptor antagonist diphenylbutylpiperidines improve glycemia in experimental obesity by inhibiting succinyl-CoA:3-ketoacid CoA transferaseSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Amanda A. Greenwell et al.|Unknown|2022Cited by 0